For the Inventor, By the Inventor

Enter assignee name

Stamford, CT, United States of America

Purdue Pharmaceutical Products L.p.

USPTO Granted Patents = 24

Trademarks = 2

Forward Citations = 269

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Thomas Jorg Mehrling (13 out of 24 patents)

Enrique Maria Ocio (7 out of 8 patents)

Yi Heng Chen (5 out of 77 patents)

4. Yu Cheng Chen (5 out of 60 patents)

5. James C Chen (4 out of 49 patents)

6. Rosaria De Filippi (3 out of 3 patents)

7. Antonio Pinto (3 out of 3 patents)

8. David Bartholomew Shine (3 out of 8 patents)

9. Claudio Festuccia (2 out of 3 patents)

10. Jonathan S Dahm (2 out of 16 patents)

11. William Louis Barnard (2 out of 16 patents)

12. Hugh Narciso (1 out of 10 patents)

13. Lars Hermann (1 out of 2 patents)

14. Phillip Burwell (1 out of 5 patents)

15. Zihong Guo (1 out of 22 patents)

24 patents: Sort by Forward Citations

1. 12440475 - Hodgkin lymphoma therapy (2025-10-14),

2. 12403130 - Pharmaceutical combinations for treating cancer (2025-09-02),

3. 12370177 - Compounds for treating brain cancer (2025-07-29),

4. 12064417 - Combination comprising a glucocorticoid and EDO-S101 (2024-08-20),

5. 12048688 - Pharmaceutical combinations for treating cancer (2024-07-30),

6. 11766424 - Hodgkin lymphoma therapy (2023-09-26),

7. 11559516 - Pharmaceutical combinations for treating cancer (2023-01-24),

8. 11541038 - Combination comprising a glucocorticoid and EDO-S101 (2023-01-03),

9. 11419853 - Compounds for treating brain cancer (2022-08-23),

10. 11266631 - Hodgkin lymphoma therapy (2022-03-08),

11. 10744120 - Combination comprising a glucocorticoid and EDO-S101 (2020-08-18),

12. 10507205 - Methods of treating opiate dependency and preventing non-oral opiate abuse among opiate addicts (2019-12-17),

13. 10406138 - Pharmaceutical combinations for treating cancer (2019-09-10),

14. 10118901 - Therapeutic agents (2018-11-06),

15. 9993482 - Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer (2018-06-12),

Purdue Pharmaceutical Products L.P. is a leading pharmaceutical company dedicated to improving patient lives. We specialize in developing and providing innovative medications in areas such as pain management, CNS disorders, and oncology. With a commitment to quality, research, and patient care, we strive to make a positive impact on global health and wellness.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#31 in Stamford, CT

#312 in Connecticut

#13,427 in US

#25,861 in the World

Stamford, CT, United States of America

Purdue Pharmaceutical Products L.p.

Forward Citations = 269

23 inventors:

Thomas Jorg Mehrling (13 out of 24 patents)

Enrique Maria Ocio (7 out of 8 patents)

Yi Heng Chen (5 out of 77 patents)

4. Yu Cheng Chen (5 out of 60 patents)

5. James C Chen (4 out of 49 patents)

Please report any incorrect information to support@idiyas.com

Loading…